GlaxoSmithKline teams with Vir Biotechnology to develop coronavirus vaccine, treatments
April 06, 2020 at 10:11 AM EDT
GSK also plans to invest $250 million in the San Francisco-based biotechnology company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|